Zdrowie i gospodarka · 28/07/2017

FDA Establishes Public Docket for Drug Products Presenting Compounding Challenges

The FDA is creating a public list of medications that pose significant challenges for compounding, allowing interested parties to submit nominations and comments, following the receipt of over 71 unique nominations.